Johnson & Johnson MedTech

Dr. Africa Wallace’s goal of delivering better outcomes consistently at scale may sound simple, but it calls for complex alignment across functions that requires time, communication and strategy. Read the full article here: https://bit.ly/3WrXmFN

We need to reimagine how we approach addressing chronic limb-threatening ischemia (CLTI). We sat down with Dr. Leigh Ann O’Banion to discuss an innovative tool designed to help bridge the CLTI treatment gap. Read the full article here: https://bit.ly/3Lpc1PT

Technology to remove and rejoin tissue has come a long way. And with an ever-changing, aging patient population, advancement and innovation are more important than ever.

In a recent interview with Jim Cramer at CNBC, Johnson & Johnson's Chairman and CEO Joaquin Duato highlighted Impella™ heart pumps as one example of the transformational technologies that Johnson & Johnson MedTech offers to our customers and patients. You can learn more about Impella here: https://lnkd.in/ewy6PMkH

In outer space, light moves through vacuums directly. But here on Earth, light has to pass (or, technically, bend) through mediums. How fast or slow it moves is its refractive index—a critical measurement that optometrists, ophthalmologists, and engineers rely on when advancing vision care that helps us see better at every age. Read the full article: https://bit.ly/4faGX12

Until recently, variability in breast implant sizing was limited, particularly for patients with larger bodies. New options are providing more choices—and more satisfactory results. Read more: https://bit.ly/432dge1

Happening now on the #TCT2025 World Connect Stream: Elevating your Clinical Practice for the New Era of Treating Cardiogenic Shock Patients. Join us in presentation theatre 4 or watch online: https://lnkd.in/d5Mh8Ara

#News: Mayo Clinic and QAS.AI are the first awardees of the Polyphonic™ AI Fund for Surgery QuickFire Challenge for their pioneering work aimed at enhancing surgical care with the potential to improve patient outcomes. The Polyphonic AI Fund for Surgery is supported by our Polyphonic Digital Ecosystem and a coalition of companies including NVIDIA and Amazon Web Services (AWS). One of the initial initiatives of the Fund is to leverage the QuickFire Challenge program with an open call for surgical AI innovation. Read more about the first QuickFire Challenge awardees here: https://bit.ly/3WWwPRj And don’t miss the opportunity to apply for the second-round cohort: https://lnkd.in/e4CFcyW2

The Heart Recovery team is at #TCT2025 and ready to answer your questions about Impella™ heart pumps! Stop by booth #1348 and say hello.

For decades, we’ve been working with surgeons and surgical stapler engineers to continuously tweak, refine and build upon our approach to tissue management. Read the full article here: https://lnkd.in/eZbwuEd6